Univ China Pharma Submits Patent Application for Compound Used as Non-Covalent BTK Kinase Inhibitor and Biological Application Thereof.
In: Global IP News: Pharmaceutical Patent News, 2024-02-24
Zeitungsartikel
Zugriff:
Titel: |
Univ China Pharma Submits Patent Application for Compound Used as Non-Covalent BTK Kinase Inhibitor and Biological Application Thereof.
|
---|---|
Zeitschrift: | Global IP News: Pharmaceutical Patent News, 2024-02-24 |
Veröffentlichung: | 2024 |
Medientyp: | Zeitungsartikel |
Sonstiges: |
|